Takeda to stop selling 13 Pfizer drugs in Japan TOKYO (Reuters) - Takeda Pharmaceutical Co, Japan's biggest drugmaker, said on Monday it will stop distributing 13 Pfizer Inc drugs it now sells in Japan at the end of this year and Pfizer itself will begin selling them from 2013. The 13 drugs include antibiotic Minomycin, anticancer agents Torisel and Mylotarg, and depression treatment Amoxan. The list did not include Viagra. Takeda said it will continue to distribute Prevenar, a pneumococcus vaccine for children, and the haemophilia B drug BeneFIX. It also said it and Pfizer will continue to work together on the arthritis drug Enbrel. Reporting by Mayumi Negishi; Editing by Michael Watson